Back to Search
Start Over
Authors’ reply to the letter to the editor regarding 'Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes'
- Source :
- Diabetes Research and Clinical Practice. 191:110018
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
Details
- ISSN :
- 01688227
- Volume :
- 191
- Database :
- OpenAIRE
- Journal :
- Diabetes Research and Clinical Practice
- Accession number :
- edsair.doi.dedup.....de8f5ca12beff38e670261a9c99cb03c
- Full Text :
- https://doi.org/10.1016/j.diabres.2022.110018